Journal
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Volume 133, Issue 2, Pages 202-207Publisher
WILEY
DOI: 10.1111/bcpt.13884
Keywords
adverse drug events; antiplatelet drugs; ischemic heart disease; pharmacogenetics; polymorphism; precision medicine